Also important are questions that explore diabetes control, symptoms that suggest hypothyroidism, history of previous surgery and medications (Tables 4, 5)
The list below is drawn from the FDA prescribing information for semaglutide [3] and tirzepatide [4], the 2023 Endocrine Society guideline [2], and the American Gastroenterological Association's 2022 clinical practice update on GLP-1 use in patients with gastrointestinal disease [5]
By following these guidelines, you can maximize the shelf life of the medication, ensuring it remains effective and safe throughout its use
It has downstream consequences on metabolic rate, insulin sensitivity, long-term weight maintenance, and overall resilience
Having a backup plan, whether that is switching to semaglutide or transitioning to brand-name tirzepatide, is prudent
Imbalances can result in loss of energy, increased irritability, sleeplessness, memory problems, and low sex drive